Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Zhipeng Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China. Hauptthemen laut MEDLINE: Autophagy, Mycobacterium tuberculosis, Protein Phosphatase 2C, Antitubercular Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research, University of Ottawa.
Abstract (Originalsprache)
Mycobacterium tuberculosis (Mtb), the infectious agent of tuberculosis (TB), causes over 1.5 million deaths globally every year. Host-directed therapies (HDT) for TB are desirable for their potential to shorten treatment and reduce the development of antibiotic resistance. Previously, we described a modular biomimetic strategy to identify SMIP-30, targeting PPM1A (IC50 = 1.19 μM), a metal-dependent phosphatase exploited by Mtb to survive intracellularly. SMIP-30 restricted the survival of Mtb in macrophages and lungs of infected mice. Herein, we redesigned SMIP-30 to create SMIP-031, which is a more potent inhibitor for PPM1A (IC50 = 180 nM). SMIP-031 efficiently increased the level of phosphorylation of S403-p62 and the expression of LC3B-II to activate autophagy, resulting in the dose-dependent clearance of Mtb in infected macrophages. SMIP-031 possesses a good pharmacokinetic profile and oral bioavailability (F = 74%). In vivo, SMIP-031 is well tolerated up to 50 mg/kg and significantly reduces the bacteria burden in the spleens of infected mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China.
- Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
ORCID-Profile: Yi Chu Liang, Cheng Luo, Jim Sun, Weibo Yang
Förderung
- CIHR
- Canadian Institutes of Health Research
- University of Ottawa
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- National Sanitarium Association
- Natural Sciences and Engineering Research Council of Canada
- National Natural Science Foundation of China
- Program of Shanghai Academic Research Leader
Zitieren
APA
Yu, Z., Liang, Y. C., Berton, S., Liu, L., Zou, J., Chen, L., Xu, Z., Luo, C., Sun, J., & Yang, W. (2024). Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00513
Vancouver
Yu Z, Liang YC, Berton S, Liu L, Zou J, Chen L, et al. Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00513
BibTeX
@article{Yu2024,
author = {Yu, Zhipeng and Liang, Yi Chu and Berton, Stefania and Liu, Liping and Zou, Jiaqi and Chen, Lu and Xu, Zhongliang and Luo, Cheng and Sun, Jim and Yang, Weibo},
title = {Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00513}
}
EUVIMED